A Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group

Author： Carlson Robert W.   O'Neill Anne M.   Goldstein Lori J.   Sikic Branimir I.   Abramson Neil   Stewart James A.   Davidson Nancy E.   Wood William C.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.24, Iss.7, 2006-09, pp. : 677-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of Ifosfamide+Doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the Eastern Cooperative Oncology Group

By Edmonson John H.   Ryan Louise M.   Falkson Carla I.   Hicks David G.   Blum Ronald H.  

Sarcoma, Vol. 7, Iss. 1, 2003-01 ,pp. : 9-11

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer

By Murad A.M.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 1, 1997-08 ,pp. : 47-53

Springer Publishing Company

Access to resources Recommend Favorite

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group

By Dimopoulos M.A.   Papadimitriou C.A.   Sarris K.   Aravantinos G.   Kalofonos C.   Gika D.   Gourgoulis G.M.   Efstathiou E.   Skarlos D.   Bafaloukos D.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 476-482

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

By Bailey H.H.   Levy D.   Harris L.S.   Schink J.C.   Foss F.   Beatty P.   Wadler S.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 464-468

Academic Press

Access to resources Recommend Favorite

Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Blessing J.A.   Ball H.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite